MedPath

Hexamethylenetetramine

Generic Name
Hexamethylenetetramine
Brand Names
Hyophen, Mandelamine, Phosphasal, Urelle, Uribel, Urimar Reformulated Oct 2013, Urin DS, Urogesic Blue Reformulated Apr 2012, Ustell, Utira
Drug Type
Small Molecule
Chemical Formula
C6H12N4
CAS Number
100-97-0
Unique Ingredient Identifier
J50OIX95QV

Overview

Methenamine is a heterocyclic organic compound with a cage-like structure similar to adamantane. In salt form it is used for the treatment of urinary tract infection (Example: methenamine hippurate which is the hippuric acid salt of methenamine).

Background

Methenamine is a heterocyclic organic compound with a cage-like structure similar to adamantane. In salt form it is used for the treatment of urinary tract infection (Example: methenamine hippurate which is the hippuric acid salt of methenamine).

Indication

For prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug is not used to treat infection and should only be used after appropriate eradication of infection with antimicrobial agents.

Associated Conditions

  • Urinary Tract Infection

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/05/01
Phase 4
Not yet recruiting
Women and Infants Hospital of Rhode Island
2025/02/05
Not Applicable
Recruiting
2024/11/29
Early Phase 1
Not yet recruiting
2022/12/21
Phase 3
Active, not recruiting
Jocelyn Fitzgerald
2021/01/14
Phase 4
Terminated
2019/09/04
Phase 4
Completed
2019/06/24
Phase 4
Withdrawn
2019/01/28
Phase 2
Completed
2017/12/20
Phase 4
Completed
2017/03/13
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Aurobindo Pharma Limited
65862-782
ORAL
1 g in 1 1
1/23/2024
Meda Pharmaceuticals
0037-6321
ORAL
81 mg in 1 1
1/13/2015
Star Pharmaceuticals, LLC
0076-0111
ORAL
120 mg in 1 1
1/24/2017
Micro Labs Limited
42571-332
ORAL
1000 mg in 1 1
11/25/2021
A.G. Marin Pharmaceutical
12539-144
ORAL
81.6 mg in 1 1
10/7/2022
Carilion Materials Management
68151-0984
ORAL
1 g in 1 1
6/18/2014
Edenbridge Pharmaceuticals LLC.
42799-105
ORAL
500 mg in 1 1
11/10/2021
Star Pharmaceuticals LLC
0076-0903
ORAL
120 mg in 1 1
1/10/2017
Mission Pharmacal Company
0178-0745
ORAL
81.6 mg in 1 1
1/22/2024
Vilvet Pharmaceuticals Inc
71186-000
ORAL
81 mg in 1 1
2/21/2019

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Methenamine Solution
国药准字H20073721
化学药品
喷雾剂
4/26/2023
Methenamine Solution
国药准字H20043851
化学药品
溶液剂
7/13/2020
Methenamine Solution
国药准字H45021084
化学药品
溶液剂
8/8/2020
Methenamine Solution
国药准字H20103051
化学药品
溶液剂
7/11/2024
Methenamine Solution
国药准字H41024617
化学药品
溶液剂(外用)
3/27/2020
Urotropine Tablets
国药准字H11022328
化学药品
片剂
9/1/2020
Urotropine Tablets
国药准字H53021750
化学药品
片剂
7/6/2020
Urotropine Tablets
国药准字H41024891
化学药品
片剂
1/9/2020
Urotropine Tablets
国药准字H50021896
化学药品
片剂
8/27/2020
Urotropine Tablets
国药准字H61022722
化学药品
片剂
8/18/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath